Richard Aranda insider trades
Open-market stock purchases and sales by Richard Aranda, Chief Medical Officer at Gossamer Bio, Inc, from SEC Form 4 filings since Jun 21, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $1.6M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $9K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $646K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $473K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $136K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $257K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $219K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $340K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $172K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $27.2K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $54.4K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $31K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $12.5K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $40.8K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $253K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $73.1K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $70.9K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $57K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $18K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $10.3K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $4.1K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $13.5K |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
Companies traded
- GOSS Gossamer Bio, Inc: 8 sales, last Mar 19, 2026